RTI-160
Chemical compound
| RTI-160 | |
|---|---|
| INN | |
| Drug class | |
| Routes of administration | |
| Pregnancy category | |
| Bioavailability | |
| Metabolism | |
| Elimination half-life | |
| Excretion | |
| Legal status | |
| CAS Number | |
| PubChem | |
| DrugBank | |
| ChemSpider | |
| KEGG | |
RTI-160 is a chemical compound that belongs to the class of phenyltropanes, which are known for their stimulant properties. It is a cocaine analog that has been studied for its potential effects on the central nervous system.
Chemical Structure and Properties
RTI-160 is structurally related to cocaine, sharing the tropane ring system but differing in the substitution pattern on the phenyl ring. The compound is characterized by the presence of a 4-chlorophenyl group, which is a key feature distinguishing it from other phenyltropanes.
The IUPAC name for RTI-160 is Methyl (1R,2R,3S,5S)-3-(4-chlorophenyl)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylate. This nomenclature reflects the stereochemistry of the molecule, which is crucial for its biological activity.
Pharmacology
RTI-160 acts primarily as a dopamine reuptake inhibitor, which means it blocks the reabsorption of dopamine into neurons, leading to increased levels of dopamine in the synaptic cleft. This mechanism is similar to that of cocaine, although RTI-160 may have different potency and selectivity profiles.
The compound has been studied in various animal models to assess its potential as a stimulant and its effects on behavior. These studies help in understanding the role of dopamine in the brain and the potential therapeutic applications or risks associated with dopamine reuptake inhibitors.
Potential Applications
Research into RTI-160 and related compounds is ongoing, with interest in their potential use in treating conditions such as attention deficit hyperactivity disorder (ADHD) and narcolepsy. However, the potential for abuse and addiction remains a significant concern, as with other stimulants.
Safety and Toxicity
As with many psychoactive substances, the safety profile of RTI-160 is not fully understood. Studies typically focus on acute effects, but long-term effects and potential toxicity require further investigation. The presence of the 4-chlorophenyl group may influence the compound's metabolism and toxicity.
Related pages
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Contributors: Prab R. Tumpati, MD